July 2017

J Psychiatry Neurosci 2017;42(4)

Editorial

Neuroimaging tests for clinical psychiatry: Are we there yet?
M. Leyton, S.H. Kennedy

Commentary

Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
L.R. Aleksandrova, A.G. Phillips, Y.T. Wang

Research Papers

Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents
T. Duan, N. Gu, Y. Wang, F. Wang, J. Zhu, Y. Fang, Y. Shen, J. Han, X. Zhang

Hemispheric lateralization abnormalities of the white matter microstructure in patients with schizophrenia and bipolar disorder
N.F. Ho, Z. Li, F. Ji, M. Wang, C.N. Kuswanto, M.Y. Sum, H.Y. Tng, Y.Y. Sitoh, K. Sim, J. Zhou

S100A10 identified in a genome-wide gene × cannabis dependence interaction analysis of risky sexual behaviours
R. Polimanti, S.A. Meda, G.D. Pearlson, H. Zhao, R. Sherva, L.A. Farrer, H.R. Kranzler, J. Gelernter

Functional MRI examination of empathy for pain in people with schizophrenia reveals abnormal activation related to cognitive perspective-taking but typical activation linked to affective sharing
D. Vistoli, M.-A. Lavoie, S. Sutliff, P.L. Jackson, A.M. Achim

Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans
S. Thiebes, G. Leicht, S. Curic, S. Steinmann, N. Polomac, C. Andreou, I. Eichler, L. Eichler, C. Zöllner, J. Gallinat,
I. Hanganu-Opatz, C. Mulert

Psychopharmacology for the Clinician

Recognition and management of antidepressant discontinuation syndrome
V. Bhat, S.H. Kennedy